🔴 Pacific Biosciences is trading 5.1% down today amid a broader biotech sector pullback

Pacific Biosciences is trading 5.1% down at $1.41 as the broader biotech sector retreats and market risk appetite cools.

• The move tracks a roughly 3% drop in biotech ETFs, suggesting the stock is reacting to sector-wide rotation rather than any company-specific catalysts.
• Today's decline follows a sector-driven bounce yesterday, as the stock pulls back from its recent gains.
• No new company-specific news or regulatory filings have been released today to account for the price action.